Suppr超能文献

细胞色素P450(CYP)、谷胱甘肽S-转移酶(GST)和磺基转移酶(SULT)基因多态性及其与吸烟的相互作用对肝细胞癌风险的影响。

The effect of CYP, GST, and SULT polymorphisms and their interaction with smoking on the risk of hepatocellular carcinoma.

作者信息

Boccia Stefania, Miele Luca, Panic Nikola, Turati Federica, Arzani Dario, Cefalo Consuelo, Amore Rosarita, Bulajic Milutin, Pompili Maurizio, Rapaccini Gianlodovico, Gasbarrini Antonio, La Vecchia Carlo, Grieco Antonio

机构信息

Institute of Public Health, Section of Hygiene, Department of Public Health, Università Cattolica del Sacro Cuore, Largo Francesco Vito 1, 00168 Rome, Italy ; IRCCS San Raffaele Pisana, Via della Pisana 235, 00163 Rome, Italy.

Institute of Internal Medicine, Gemelli Hospital, Università Cattolica del Sacro Cuore, Largo Francesco Vito 1, 00168 Rome, Italy ; Internal Medicine and Gastroenterology Unit, Complesso Integrato Columbus, Via Giuseppe Moscati 31-33, 00168 Rome, Italy.

出版信息

Biomed Res Int. 2015;2015:179867. doi: 10.1155/2015/179867. Epub 2015 Jan 14.

Abstract

Aim. The aim of our study was to assess whether selected single nucleotide polymorphisms of CYP1A1 and 2E1, GSTM1, GSTT1, and SULT1A1 influence susceptibility towards HCC, considering their interaction with cigarette smoking. Methods. We recruited HCC cases and controls among patients admitted to the hospital "Agostino Gemelli," from January 2005 until July 2010. Odds ratios (OR) of HCC were derived from unconditional multiple logistic regression. Gene-gene and gene-smoking interaction were quantified by computing the attributable proportion (AP) due to biological interaction. Results. The presence of any CYP2E1 () 5B variant allele (OR: 0.23; 95% CI: 0.06-0.71) and CYP2E1 () 6 variant allele (OR: 0.08; 95% CI: 0.01-0.33) was inversely related to HCC. There was a borderline increased risk among carriers of combined CYP1A1 () 2A and SULT1A1 variant alleles (OR: 1.67; 95% CI: 0.97-3.24). A significant biological interaction was observed between GSTT1 and smoking (AP = 0.48; 95% CI: 0.001-0.815), with an OR of 3.13 (95% CI: 1.69-5.82), and borderline significant interaction was observed for SULT1A1 and smoking (AP = 0.36; 95% CI: -0.021-0.747), with an OR of 3.05 (95% CI: 1.73-5.40). Conclusion. CYP2E1 () 5B and CYP2E1 (*) 6 polymorphisms have a favourable effect on the development of HCC, while polymorphisms of GSTT1 and SULT1A1 might play role in increasing the susceptibility among smokers.

摘要

目的。我们研究的目的是评估细胞色素P450 1A1(CYP1A1)和2E1、谷胱甘肽S -转移酶M1(GSTM1)、谷胱甘肽S -转移酶T1(GSTT1)以及磺基转移酶1A1(SULT1A1)的特定单核苷酸多态性是否会影响肝癌易感性,并考虑它们与吸烟的相互作用。方法。我们在2005年1月至2010年7月期间入住“阿戈斯蒂诺·杰梅利”医院的患者中招募了肝癌病例和对照。肝癌的比值比(OR)来自无条件多因素逻辑回归。通过计算生物学相互作用的归因比例(AP)来量化基因 - 基因和基因 - 吸烟相互作用。结果。任何CYP2E1()5B变异等位基因(OR:0.23;95%可信区间:0.06 - 0.71)和CYP2E1()6变异等位基因(OR:0.08;95%可信区间:0.01 - 0.33)的存在与肝癌呈负相关。携带CYP1A1()2A和SULT1A1变异等位基因组合的个体风险有临界性增加(OR:1.67;95%可信区间:0.97 - 3.24)。观察到GSTT1与吸烟之间存在显著的生物学相互作用(AP = 0.48;95%可信区间:0.001 - 0.815),OR为3.13(95%可信区间:1.69 - 5.82),并且观察到SULT1A1与吸烟之间存在临界显著相互作用(AP = 0.36;95%可信区间: - 0.021 - 0.747),OR为3.05(95%可信区间:1.73 - 5.40)。结论。CYP2E1()5B和CYP2E1(*)6多态性对肝癌的发生有有利影响,而GSTT1和SULT1A1多态性可能在增加吸烟者的易感性方面起作用。

相似文献

4
CYP1A2*1C, CYP2E1*5B, and GSTM1 polymorphisms are predictors of risk and poor outcome in head and neck squamous cell carcinoma patients.
Oral Oncol. 2009 Sep;45(9):e73-9. doi: 10.1016/j.oraloncology.2009.03.004. Epub 2009 May 12.
9
Genetic polymorphisms of tobacco- and alcohol-related metabolizing enzymes and the risk of hepatocellular carcinoma.
J Cancer Res Clin Oncol. 2003 Jun;129(6):355-60. doi: 10.1007/s00432-003-0439-5. Epub 2003 May 21.
10
Combined analysis of germline polymorphisms of p53, GSTM1, GSTT1, CYP1A1, and CYP2E1: relation to the incidence rate of cervical carcinoma.
Cancer. 2000 May 1;88(9):2082-91. doi: 10.1002/(sici)1097-0142(20000501)88:9<2082::aid-cncr14>3.0.co;2-d.

引用本文的文献

1
Hepatocellular Carcinoma: A Comprehensive Review.
Diseases. 2025 Jul 2;13(7):207. doi: 10.3390/diseases13070207.
3
The Role of Sulfotransferases in Liver Diseases.
Drug Metab Dispos. 2020 Sep;48(9):742-749. doi: 10.1124/dmd.120.000074. Epub 2020 Jun 25.
4
Single Nucleotide Polymorphisms of and Decrease the Risk of Hepatocellular Carcinoma.
Biomed Res Int. 2019 May 9;2019:6436825. doi: 10.1155/2019/6436825. eCollection 2019.
5
GSTM1 and GSTT1 null genotype increase the risk of hepatocellular carcinoma: evidence based on 46 studies.
Cancer Cell Int. 2019 Mar 29;19:76. doi: 10.1186/s12935-019-0792-3. eCollection 2019.
6
The Interaction of Smoking with Gene Polymorphisms on Four Digestive Cancers: A Systematic Review and Meta-Analysis.
J Cancer. 2018 Apr 6;9(8):1506-1517. doi: 10.7150/jca.22797. eCollection 2018.

本文引用的文献

1
Coffee reduces risk for hepatocellular carcinoma: an updated meta-analysis.
Clin Gastroenterol Hepatol. 2013 Nov;11(11):1413-1421.e1. doi: 10.1016/j.cgh.2013.04.039. Epub 2013 May 6.
2
Genetic polymorphisms of glutathione S-transferase genes GSTM1, GSTT1 and risk of hepatocellular carcinoma.
PLoS One. 2012;7(11):e48924. doi: 10.1371/journal.pone.0048924. Epub 2012 Nov 20.
3
Metabolic syndrome and hepatocellular carcinoma risk.
Br J Cancer. 2013 Jan 15;108(1):222-8. doi: 10.1038/bjc.2012.492. Epub 2012 Nov 20.
7
Hepatocellular carcinoma risk factors and disease burden in a European cohort: a nested case-control study.
J Natl Cancer Inst. 2011 Nov 16;103(22):1686-95. doi: 10.1093/jnci/djr395. Epub 2011 Oct 21.
8
CYP1A1 MspI and exon7 gene polymorphisms and lung cancer risk: an updated meta-analysis and review.
J Exp Clin Cancer Res. 2011 Oct 20;30(1):99. doi: 10.1186/1756-9966-30-99.
9
Evaluation of the association studies of single nucleotide polymorphisms and hepatocellular carcinoma: a systematic review.
J Cancer Res Clin Oncol. 2011 Jul;137(7):1095-104. doi: 10.1007/s00432-010-0970-0. Epub 2011 Jan 15.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验